A total of 63 patients were included, corresponding to a hospital prevalence of 34.5% (CI: 28.9 - 40.2). The mean age was 75.0 ± 6.4 years. The age group 70 - 79 years was most represented. There was a female predominance, with a sex ratio (M/F) of 0.5 (Table 1).

Table 1. Sociodemographic characteristics of study Population.

Hypertension was present in 81.0% of patients being the most common comorbidity followed by a sedentary lifestyle in 74.6% (Figure 1).

HBP: High Blood Pressure; HF: Heart Failure; CKD: Chronic Kidney Disease.

Figure 1. Comorbidities and Cardiovascular risk factors.

Overall, 52 (82.5%) had global heart-failure symptoms. The most frequent symptom was dyspnea on exertion (n = 53; 84.1%). Six patients (9.5%) were asymptomatic at baseline.

The most frequent NYHA class of dyspnea was stage III (n = 21; 33.3%) followed by stage II (n = 20; 31.7%).

At admission 33 (52.4%) had an elevated blood pressure and 42 (66.7%) were polypneic (>20 cycles/min); altered consciousness (GCS < 15) occurred in 6 patients (9.5%). Concerning the signs of HF, right heart failure signs were present in majority of patients: lower-limb edema 41 (65.1%), jugular venous distension 38 (60.3%). Left heart failure signs were dominated by crackles 29 (46.0%) followed by displaced apex beat 25 (39.7). (See Table 2). 41 patients (65.1%) of our study population were admitted with 24 patients being admitted for Acute Heart Failure. Of the 24 patients admitted for acute HF, 21 (87.5%) had congestive HF and 3 (12.5%) had acute pulmonary edema. The dominant decompensating factor recorded was non-adherence to treatment. (See Figure 2 and Table 3).

Table 2. Clinical profile of patients with HF in our study population.

RHF:Right Heart failure, LHF:Left heart failure, HR:Heart rate, RR:Respiratory rate.

Table 3. Decompensating factors for HF and mode of decompensation of HF.

HF: Heart Failure.

HF: Heart Failure.

Figure 2. Distribution of admissions in study population.

A geriatric evaluation carried out by a geriatrician with the ICOPE application was based on evaluating the intrinsic capacity by assessing the physical and mental capacities and frailty assessing the vulnerability to health issues. Thus, the decline in intrinsic capacity was the most common finding on comprehensive geriatric evaluation with 41 patients (65.1%) recorded as having a decreased intrinsic capacity. Frailty was present in 27 patients (42.9%). Both decrease intrinsic capacity and frailty were present in 100% of patients aged 85 years and above. Cognitive impairment was identified in 14 (22.2%), depressive symptoms in 23 (36.5%), malnutrition in 9 (14.3%), and social dependence in 19 (30.2%) (Table 4).

Table 4. Distribution of geriatric syndromes in study population.

Arrythmia was the most frequent ECG abnormality in the study population seen in 66.7% of patients with atrial fibrillation being the most common arrythmia; 39.7% of patients. Only 9 patients (14.3%) had signs of previous myocardial ischemia (Table 5). On cardiac echography, Left ventricular hypertrophy (LVH) was the predominant abnormality marked by eccentric LVH in 27 patients (42.8%), concentric LVH in 23 patients (36.5%) and concentric remodeling in 13 patients (20.6%). The majority of patients (58.7%) had a preserved LVEF while mildly reduced LVEF and reduced LVEF represented 17.5% and 23.8% respectively. Patients aged ≥ 85 years had the highest prevalence of reduced LVEF.

Table 5. Electrocardiographic abnormalities in our study population.

Chest radiography showed cardiomegaly in 61.9% being the most common radiographic abnormality in the study population followed by pulmonary congestion in 23 patients (43.4%). Laboratory results found hypokalemia in 28.6%, anemia in 22.2%, and renal dysfunction in 15.9% of the patients (Table 6).

Table 6. Paraclinical profile of study population.

In our study, the hospital prevalence of HF was 34.5% (CI: 28.9 - 40.2). This is similar to the 40.8% reported by Mfeukeu et al. in 2021 in the same hospitals [1], and to the 49.7% found by Bivigou et al. in Gabon in 2018 [4]. The mean age of our patients was 75.0 ± 6.4 years, with the 70 - 79 year group most represented. This is close to the 66 ± 15 years reported by Mfeukeu et al. and the 57.4 ± 17 years reported by Bivigou et al. [1][4]. Our average age is also consistent with data from developed countries where Saudubray et al. in France and Obata et al. in Japan reported averages of 79 and 84.7 years, respectively [5][6]. The female predominance observed (sex ratio 0.5) has also been reported in other African and international series [1][4].

Hypertension was the leading comorbidity (81.0%), followed by sedentary lifestyle (74.6%) and diabetes (28.6%). The frequency of hypertension in our series is higher than that reported in other African and Asian studies where prevalence usually ranges around 60% [4][7]. This may be explained by the older age of our population, as vascular aging is an established contributor to hypertension.

Dyspnea on exertion was the most common symptom (84.1%), and the majority of patients were in NYHA class III (33.3%) or II (31.7%). These findings are consistent with reports from the literature that indicate advanced dyspnea is the predominant mode of presentation in African HF patients [8]-[10]. Altered consciousness was present in 9.5% of patients, reflecting the severity of decompensation and mechanisms as cerebral hypoxia and severe hyponatremia.

Acute HF was the most frequent mode of admission, observed in 38.1% of patients. This is higher than the 33.3% reported by Boombhi et al. in 2017 [11]. The main decompensating factor was non-adherence to treatment (83.3%), a finding similar to that of Bivigou et al. in Libreville who reported 88.6% [4]. This result is also in line with Kuate et al., who found a prevalence of 35.3% in 2021 [1]. Poor treatment adherence has been widely described among African HF patients, explained in part by low therapeutic education and socioeconomic constraints [1][12]. In deed, in our milieu, there is no national medical support in terms of social insurance. Therefore each patient has to afford his management which limits the adherence and when it comes ton therapeutic education, if consider all the previous cross sectional studies carried out, the majority of patients were not aware of the long term aspect of their treatment. Besides in our milieu, its very difficult for the families to invest a lot of finances in elderly patients for according to them their prognosis most of the time are unfavorable.

Signs of right heart failure were predominant, particularly lower-limb edema (65.1%) and jugular venous distension (60.3%), while left-sided signs were dominated by crackles (46.0%). These findings are comparable to those from earlier Cameroonian series [9].

Decline in intrinsic capacity was the most common finding on comprehensive geriatric evaluation. Frailty was documented in 42.9% consistent with the range of 15% - 74% reported internationally [13]. Our results differ from those of Essomba et al., who found dependence as the most frequent geriatric syndrome (70.5%) [14], while in our study dependence was noted in only 30.2% of patients. This discrepancy may be related to differences in assessment tools, since Essomba et al. used the ADL scale while we applied the ICOPE questionnaire.

Malnutrition was present in 14.3%, with prevalence rising in patients ≥85 years. Obata et al. in Japan reported 44.1% malnutrition assessed by GNRI [6]. Our prevalence is closer to that found by Essomba et al. in Cameroon (17%) [15], likely reflecting the use of the same MNA-SF tool.

Arrhythmia was the most common ECG abnormality, present in 66.7% of patients, with atrial fibrillation being the most frequent rhythm disorder (39.7%). These findings are in line with Sung et al. in China (33.8%) [7] and Obata et al. in Japan (53.8%). Signs of previous myocardial ischemia were present in 14.3%, reflecting the contribution of ischemic heart disease to HF in the elderly.

On echocardiography, preserved LVEF was the predominant phenotype (58.7%), while 17.5% had mildly reduced LVEF and 23.8% reduced LVEF. Boombhi et al. reported preserved EF in 49% [11], which is close to our result. As in other studies, patients ≥85 years in our series had a higher frequency of HF with reduced LVEF, suggesting age-related decline in systolic function.

Our study has some limitations. First, the sample size was relatively small and limited to two hospitals, which may restrict the generalizability of our findings. Second, the cross-sectional design does not allow inference of causal relationships between comorbidities, precipitating factors, and outcomes. Third, some investigations such as BNP were rarely performed, reflecting local practice constraints, and this limited our ability to analyze their role in the clinical profile of HF. Finally, the use of retrospective medical records for part of the data collection may have introduced information bias.